BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B

Commiphora Myrrha

116+ PubMed studies analyzed · 5 RCTs · Evidence Score: 32.5

Research Domains

Commiphora Myrrha has been studied across 14 research domains including 🔬 Inflammation, 🔬 Oncology, 💊 Pain, 🛡️ Immunity, ✨ Skin & Hair. The primary research focus is 🔬 Inflammation with 17% of studies addressing this area.

Traditional Use (Ayurveda)

Known as moyao / 沒藥 in Ayurveda. Virya (potency): Heart, Liver. Karma (actions): Breaks Blood stasis, Stops pain, Treats metal-weapon wounds and cane-strike wounds, Treats all malign sores, hemorrhoids and fistulas, Treats sudden bleeding, Treats eye screen opacity, dizziness, pain and redness of the ocular surface, Breaks concretions, conglomerations, accumulations and gatherings, Breaks old Blood stasis from damage and injury, Reduces swelling and pain, Addresses deficiency of Heart and Gallbladder, insufficiency of Liver Blood, Descends the fetus, Treats postpartum Heart and abdominal Blood and Qi pain.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Commiphora Myrrha, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

eriobotrya
6077 shared targets
Syzygium
6048 shared targets
Nelumbo
6323 shared targets
tussilago
5795 shared targets
scutellaria
6128 shared targets
bupleurum
6094 shared targets
prunus
6066 shared targets
mosla
5133 shared targets
agastache
5399 shared targets
Panax
6661 shared targets
Loading evidence profile...

This evidence profile for Commiphora Myrrha is generated deterministically from 116 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.